[Increase of appetite by Nuran in liver diseases].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001066:Appetite; D001069:Appetite Regulation; D001835:Body Weight / Q000187:drug effects; D003533:Cyproheptadine / Q000627:therapeutic use*; D005234:Fatty Liver / Q000150:complications / Q000188:drug therapy; D001068:Feeding and Eating Disorders / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006505:Hepatitis / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications / Q000188:drug therapy; D008107:Liver Diseases / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy; D011183:Postoperative Complications / Q000188:drug therapy; D013274:Stomach Neoplasms / Q000188:drug therapy; D013997:Time Factors
D003533:Cyproheptadine
Nuran zur Appetitsteigerung bei Leberkranken.